08 . 12 .2021
Press release
Galderma announces relocation of U.S. Headquarters to downtown Dallas
03 . 12 .2021
Press release
Galderma announces new data demonstrating the positive anti-inflammatory effect and mode of action of nemolizumab in patients with moderate to severe Prurigo Nodularis
29 . 11 .2021
Press release
Galderma to acquire award-winning ALASTIN Skincare® enhancing its integrated dermatology platform to continue delivering the best experience to patients
22 . 11 .2021
Press release
Galderma leads oral presentation on hyaluronic acid filler safety insights at ASDS 2021 Annual Meeting
30 . 09 .2021
Press release
RESTYLANE®, the original stabilized hyaluronic acid filler, celebrates 25 years of unmatched achievement
30 . 09 .2021
Press release
RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers
29 . 09 .2021
Press release
Galderma presents new nemolizumab data at EADV reinforcing rapid onset of action and consistent relief of symptoms for people with prurigo nodularis and atopic dermatitis
28 . 09 .2021
Press release
Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL® at the 2021 EADV Congress
27 . 09 .2021
Press release
Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative